Cannabis
North America will continue to dominate the market during the forecast period
Hi, what are you looking for?
Mugglehead Investment Magazine
Cannabis
The 'comprehensive multi-analysis study' will test the company's FAIMS technology and its ability to detect THC in breath
Cannabis
The company says the FDA is very interested in developing IHL-216A for the treatment of TBI
Sleep
The disease tends to show itself years before patients are diagnosed with more serious conditions
Cannabis
Panaxia will manage manufacturing with Neuraxpharm responsible for marketing and distribution
Canada
New amendment to the Mental Health Services Protection Regulation has been initiated to effectively safeguard patients
Cannabis
The new products are said to work in unison with the endocannabinoid system
Business
The company attributes its recent financial success to CBD and oil-absorbing product distribution
Psychedelics
The company plans to use mushroom tea to treat patients pending regulatory approvals
Psychedelics
Company intends to provide ketamine therapy at a much lower price than a visit to the clinic would cost
Medical and Pharmaceutical
Medical and Pharmaceutical
